Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
    • Podcast
  • Press Release
  • Media Coverage
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
    • Podcast
  • Press Release
  • Media Coverage
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » Northwestern Part of New Big Ten Cancer Research Consortium
Uncategorized

Northwestern Part of New Big Ten Cancer Research Consortium

By Roger AndersonJun 14, 2013
Share
Facebook Twitter Email

Opponents on the football field, a group of eleven schools from the Big Ten athletic conference have come together to launch an ambitious new effort against a common foe: cancer.

“By uniting to transform cancer research through collaborative oncology trials, we will be able to leverage the scientific and clinical expertise of the Big Ten universities,” said Steven Rosen, MD, Genevieve E. Teuton Professor of Medicine and director of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. “The consortium will benefit patients because researchers will work together to turn ideas into potential new treatments. I view this as the beginning of a broad spectrum of potential research, training, and care initiatives that will benefit our patients and society.”

Launched in Chicago earlier this month, the Big Ten Cancer Research Consortium is meant to transform cancer research through collaborative oncology trials that leverage the scientific and clinical expertise of each university.

“This is a rare opportunity for the universities to work together as part of a regional team science initiative to advance cancer research,” said Patrick J. Loehrer Sr., MD, director of the Indiana University Melvin and Bren Simon Cancer Center. “The advantage of this, particularly during a time of austerity for research, is that we can build upon the strengths of the institutions and fortify some of the shortcomings.”

Newly developed clinical trials will be linked to molecular diagnostics, enabling researchers to understand what drives the cancers to grow and what might be done to stop them from growing.

The consortium will also leverage geographical locations and existing relationships among cancer centers.

“For research to be truly impactful, we must work together,” said Maha Hussain, MD, associate director of clinical research at the University of Michigan Comprehensive Cancer Center. “The synergy, the collaboration, the implementation all are aimed at one ultimate goal – making a real difference for patients.”

The consortium is meant to create a unique team-research culture in which senior faculty work with and mentor the research leaders of tomorrow. The consortium will provide junior faculty and fellows the opportunity to write, conduct and complete trials, which would not normally be done at a single institution or on a national level for young investigators.

The 11 schools that comprise the Big Ten Cancer Research Consortium are: Indiana University, Northwestern University, Penn State University, Purdue University, Rutgers University, the University of Illinois, University of Iowa, University of Michigan, University of Minnesota, University of Nebraska, and University of Wisconsin.

Indianapolis-based Hoosier Oncology Group will serve as the administrative headquarters for the consortium.

Research
Share. Facebook Twitter Email

Related Posts

Hospitals Bound to Patient Safety Rules that Aren’t all Backed by Evidence

Jun 24, 2022

Identifying Protein Interactions that Promote Cancer Growth

Jun 24, 2022

Calcium Channel Blockers May Improve Chemotherapy Response

Jun 21, 2022

Comments are closed.

Latest News

Hospitals Bound to Patient Safety Rules that Aren’t all Backed by Evidence

Jun 24, 2022

Identifying Protein Interactions that Promote Cancer Growth

Jun 24, 2022

Combination Treatment May Improve Quality of Life in Kidney Cancer

Jun 23, 2022

Calcium Channel Blockers May Improve Chemotherapy Response

Jun 21, 2022

Expanded Role for Calcium Channels in T-Cells

Jun 17, 2022
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
20220607_Feinberg Campus_0070
20220607_Feinberg Campus_0066
20220607_Feinberg Campus_0054
Northwestern University 2022. Photo by Jim Prisching
20220607_Feinberg Campus_0077
20220607_Feinberg Campus_0063
20220607_Feinberg Campus_0111
20220607_Feinberg Campus_0083
20220607_Feinberg Campus_0018
20220607_Feinberg Campus_0023
20220607_Feinberg Campus_0072 (2)
20220607_Feinberg Campus_0120

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2022 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.